Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jon M, Appel"'
Autor:
Heidi M Christensen, Niels Fogh-Andersen, Bo Zerahn, Susanne Møller, Bent Ejlertsen, Dorte Nielsen, Jon M Appel, Peter Søgaard, Benny Vittrup Jensen
Publikováno v:
Acta Oncologica. 51:1054-1061
Newer studies raise concern that adjuvant anthracycline treatment for breast cancer (BC) causes long-term heart damage. We aimed to examine whether heart failure or impairment could be demonstrated several years after low-dose epirubicin-based adjuva
Autor:
Jon M Appel, Peter Bo Hansen, Kåre Sander, Jacob E. Møller, Anders Krarup-Hansen, Finn Gustafsson
Publikováno v:
Congestive Heart Failure. 18:291-294
Anthracycline treatments are hampered by dose-related cardiotoxicity, frequently leading to heart failure (HF) with a very poor prognosis. The authors report a case of a 19-year-old man developing HF after anthracycline treatment for Ewing sarcoma. D
Autor:
Jon M, Appel, Kåre, Sander, Peter B, Hansen, Jacob E, Møller, Anders, Krarup-Hansen, Finn, Gustafsson
Publikováno v:
Congestive heart failure (Greenwich, Conn.). 18(5)
Anthracycline treatments are hampered by dose-related cardiotoxicity, frequently leading to heart failure (HF) with a very poor prognosis. The authors report a case of a 19-year-old man developing HF after anthracycline treatment for Ewing sarcoma. D
Publikováno v:
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 24(2)
Background It has been hypothesized that the extent of acute anthracycline-induced cardiotoxicity reflects the risk for late development of heart failure. The aim of this study was to examine if short-term changes in cardiac function can be detected
Publikováno v:
Acta oncologica (Stockholm, Sweden). 46(5)
Anthracyclines are effective drugs used in a wide range of malignant diseases. The drugs have frequent, serious adverse effects including cardiotoxicity and resulting heart failure. Systematic reviews, meta-analyses and other relevant studies were id